ProQR Therapeutics Names Hom as CFO, Lopez Lopez as Chief Medical Officer

Dow Jones

04/14

By Robb M. Stewart

ProQR Therapeutics has turned to a new chief financial officer and fresh chief medical officer to support the next phase of growth for the RNA therapies developer.

The Netherlands-based, Nasdaq-listed company said Monday it appointed Dennis Hom as finance chief and Cristina Lopez Lopez as chief medical officer to support the advancement of its Axiomer platform technology and pipeline of RNA editing programs as it enters the clinical stage.

Chief Financial Officer Jurriaan Dekkers and Chief Corporate Development Officer Rene Beukema will step down from their roles.

Hom most recently was CFO and head of corporate development at Sagimet Biosciences. Lopez most recently she served as global head of neurodegeneration at Johnson & Johnson.

Write to Robb M. Stewart at robb.stewart@wsj.com

(END) Dow Jones Newswires

April 14, 2025 07:44 ET (11:44 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2527159463"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2527159463\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2527159463?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-14 19:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527159463","market":"us","top_or_hot":-1,"title":"ProQR Therapeutics Names Hom as CFO, Lopez Lopez as Chief Medical Officer","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Robb M. Stewart \n</p>\n<pre>\n \n</pre>\n<p>\n  ProQR <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> has turned to a new chief financial officer and fresh chief medical officer to support the next phase of growth for the RNA therapies developer. \n</p>\n<p>\n  The Netherlands-based, Nasdaq-listed company said Monday it appointed Dennis Hom as finance chief and Cristina Lopez Lopez as chief medical officer to support the advancement of its Axiomer platform technology and pipeline of RNA editing programs as it enters the clinical stage. \n</p>\n<p>\n  Chief Financial Officer Jurriaan Dekkers and Chief Corporate Development Officer Rene Beukema will step down from their roles. \n</p>\n<p>\n  Hom most recently was CFO and head of corporate development at Sagimet Biosciences. Lopez most recently she served as global head of neurodegeneration at Johnson &amp; Johnson. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 14, 2025 07:44 ET (11:44 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ProQR Therapeutics Names Hom as CFO, Lopez Lopez as Chief Medical Officer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProQR Therapeutics Names Hom as CFO, Lopez Lopez as Chief Medical Officer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-14 19:44</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Robb M. Stewart \n</p>\n<pre>\n \n</pre>\n<p>\n  ProQR <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> has turned to a new chief financial officer and fresh chief medical officer to support the next phase of growth for the RNA therapies developer. \n</p>\n<p>\n  The Netherlands-based, Nasdaq-listed company said Monday it appointed Dennis Hom as finance chief and Cristina Lopez Lopez as chief medical officer to support the advancement of its Axiomer platform technology and pipeline of RNA editing programs as it enters the clinical stage. \n</p>\n<p>\n  Chief Financial Officer Jurriaan Dekkers and Chief Corporate Development Officer Rene Beukema will step down from their roles. \n</p>\n<p>\n  Hom most recently was CFO and head of corporate development at Sagimet Biosciences. Lopez most recently she served as global head of neurodegeneration at Johnson &amp; Johnson. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 14, 2025 07:44 ET (11:44 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2527159463","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527159463","pubTimestamp":1744631040,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"ProQR Therapeutics has turned to a new chief financial officer and fresh chief medical officer to support the next phase of growth for the RNA therapies developer.The Netherlands-based, Nasdaq-listed company said Monday it appointed Dennis Hom as finance chief and Cristina Lopez Lopez as chief medical officer to support the advancement of its Axiomer platform technology and pipeline of RNA editing programs as it enters the clinical stage.Chief Financial Officer Jurriaan Dekkers and Chief Corporate Development Officer Rene Beukema will step down from their roles.Hom most recently was CFO and head of corporate development at Sagimet Biosciences. Lopez most recently she served as global head of neurodegeneration at Johnson & Johnson.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LENZ":"Therapeutics","BK4139":"生物科技","PRQR":"ProQR Therapeutics N.V.","BK4007":"制药"},"translate_title":"ProQR Therapeutics任命Hom为首席财务官，Lopez Lopez为首席医疗官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"PRQR":0.9},"content_text":"By Robb M. Stewart \n\n\n \n\n\n  ProQR Therapeutics has turned to a new chief financial officer and fresh chief medical officer to support the next phase of growth for the RNA therapies developer. \n\n\n  The Netherlands-based, Nasdaq-listed company said Monday it appointed Dennis Hom as finance chief and Cristina Lopez Lopez as chief medical officer to support the advancement of its Axiomer platform technology and pipeline of RNA editing programs as it enters the clinical stage. \n\n\n  Chief Financial Officer Jurriaan Dekkers and Chief Corporate Development Officer Rene Beukema will step down from their roles. \n\n\n  Hom most recently was CFO and head of corporate development at Sagimet Biosciences. Lopez most recently she served as global head of neurodegeneration at Johnson & Johnson. \n\n\n \n\n\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 14, 2025 07:44 ET (11:44 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}